LRG1 inhibits hepatic macrophage activation by enhancing TGF-β1 signaling to alleviate MAFLD in mice.
10.12122/j.issn.1673-4254.2023.07.13
- Author:
Longfei XU
1
;
Jing HAN
1
;
Zhe YANG
1
;
Yanping YANG
1
;
Jinhui CHEN
1
;
Xijun WU
2
;
Qi WANG
1
;
Yan HONG
1
Author Information
1. Department of Histology and Embryology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
2. Clinical Laboratory, Jinyang Hospital, Guizhou Medical University, Guiyang 550025, China.
- Publication Type:Journal Article
- Keywords:
hepatic macrophages;
leucine-rich α-2-glycoprotein 1;
metabolic dysfunction-associated fatty liver disease;
steatosis;
transforming growth factor-β1
- MeSH:
Animals;
Mice;
Transforming Growth Factor beta1;
Macrophage Activation;
Signal Transduction;
Non-alcoholic Fatty Liver Disease;
Culture Media, Conditioned;
Glycoproteins
- From:
Journal of Southern Medical University
2023;43(7):1164-1171
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the effect of leucine-rich α-2-glycoprotein (LRG1) derived from hepatocytes on activation of hepatic M1 Kupffer cells.
METHODS:A metabolic dysfunction-associated fatty liver disease (MAFLD) model was established in BALB/c mice by high-fat diet (HFD) feeding for 16 weeks. Oleic acid was used to induce steatosis in primary cultures of mouse hepatocytes. The mRNA and protein expressions of LRG1 in mouse liver tissues and hepatocytes were detected by real-time PCR and Western blotting. Primary hepatic macrophages were stimulated with the conditioned medium (CM) from steatotic hepatocyte along with LRG1 or transforming growth factor-β1 (TGF-β1), or both for 24 h, and the expression levels of inducible nitric oxide synthase (iNOS) was detected with Western botting, and the mRNA expressions of iNOS, chemokine ligand 1 (CXCL-1) and interleukin-1β (IL-1β) were measured by RT-PCR. The MAFLD mice were injected with LRG1 (n=6), TGF-β1 (n=6), or both (n=6) through the caudal vein, and the live tissues were collected for HE staining and immumohistochemical detection of F4/80 expression; the mRNA expressions of iNOS, CXCL-1 and IL-1β in liver tissues were detected using RT-PCR.
RESULTS:The mRNA and protein expression levels of LRG1 were significantly downregulated in the liver tissues of MAFLD mice and steatotic hepatocytes (P < 0.05). Treatment of the hepatic macrophages with CM from steatosis hepatocytes significantly enhanced the mRNA expression levels of iNOS, CXCL-1 and IL-1β, and these changes were significantly inhibited by the combined treatment with TGF-β1 and LRG1 (P < 0.05). In MAFLD mice, injections with either LRG1 or TGF-β1 alone reduced hepatic lipid deposition and intrahepatic macrophage infiltration, and these effects were significantly enhanced by their combined treatment, which also more strongly inhibited the mRNA expression levels of iNOS, CXCL-1 and IL-1β (P < 0.05).
CONCLUSION:LRG1 inhibits hepatic macrophage infiltration by enhancing TGF-β1 signaling to alleviate fatty liver inflammation in MAFLD mice.
